Works by Tanaka, Naritaka

Results: 27
    1

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    2
    3

    Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 3, p. 201, doi. 10.1159/000540841
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    4
    5
    6

    Surgical treatment for nonspecific esophageal motility disorders.

    Published in:
    Surgery Today, 2013, v. 43, n. 8, p. 877, doi. 10.1007/s00595-012-0356-9
    By:
    • Inose, Takanori;
    • Miyazaki, Tatsuya;
    • Suzuki, Shigemasa;
    • Tanaka, Naritaka;
    • Sakai, Makoto;
    • Sano, Akihiko;
    • Yokobori, Takehiko;
    • Sohda, Makoto;
    • Nakajima, Masanobu;
    • Fukuchi, Minoru;
    • Kato, Hiroyuki;
    • Kuwano, Hiroyuki
    Publication type:
    Article
    7

    Management of Barrett's esophageal carcinoma.

    Published in:
    Surgery Today, 2013, v. 43, n. 4, p. 353, doi. 10.1007/s00595-012-0468-2
    By:
    • Miyazaki, Tatsuya;
    • Inose, Takanori;
    • Tanaka, Naritaka;
    • Yokobori, Takehiko;
    • Suzuki, Shigemasa;
    • Ozawa, Daigo;
    • Sohda, Makoto;
    • Nakajima, Masanobu;
    • Fukuchi, Minoru;
    • Kato, Hiroyuki;
    • Kuwano, Hiroyuki
    Publication type:
    Article
    8
    9
    10
    11
    12

    Quantitative analysis of cisplatin sensitivity of human esophageal squamous cancer cell lines using in-air micro-PIXE.

    Published in:
    Cancer Science, 2010, v. 101, n. 6, p. 1487, doi. 10.1111/j.1349-7006.2010.01542.x
    By:
    • Tanaka, Naritaka;
    • Kimura, Hitoshi;
    • Faried, Ahmad;
    • Sakai, Makoto;
    • Sano, Akihiko;
    • Inose, Takanori;
    • Sohda, Makoto;
    • Okada, Koji;
    • Nakajima, Masanobu;
    • Miyazaki, Tatsuya;
    • Fukuchi, Minoru;
    • Kato, Hiroyuki;
    • Asao, Takayuki;
    • Kuwano, Hiroyuki;
    • Satoh, Takahiro;
    • Oikawa, Masakazu;
    • Kamiya, Tomihiro;
    • Arakawa, Kazuo
    Publication type:
    Article
    13
    14

    Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 853, doi. 10.1007/s00280-013-2076-2
    By:
    • Miyazaki, Tatsuya;
    • Sohda, Makoto;
    • Tanaka, Naritaka;
    • Suzuki, Shigemasa;
    • Ieta, Keisuke;
    • Sakai, Makoto;
    • Sano, Akihiko;
    • Yokobori, Takehiko;
    • Inose, Takanori;
    • Nakajima, Masanobu;
    • Fukuchi, Minoru;
    • Ojima, Hitoshi;
    • Kato, Hiroyuki;
    • Kuwano, Hiroyuki
    Publication type:
    Article
    15

    ASO Visual Abstract: Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score—A Multicenter Study.

    Published in:
    2024
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Abstract
    16

    Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 13, p. 9023, doi. 10.1245/s10434-024-16161-4
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    17
    18

    Surgical Treatment for Esophageal Cancer.

    Published in:
    Digestive Surgery, 2007, v. 24, n. 2, p. 88, doi. 10.1159/000101894
    By:
    • Kato, Hiroyuki;
    • Fukuchi, Minoru;
    • Miyazaki, Tatsuya;
    • Nakajima, Masanobu;
    • Tanaka, Naritaka;
    • Inose, Takanori;
    • Kimura, Hitoshi;
    • Faried, Ahmad;
    • Saito, Kana;
    • Sohda, Makoto;
    • Fukai, Yasuyuki;
    • Masuda, Norihiro;
    • Manda, Ryokuhei;
    • Ojima, Hitoshi;
    • Tsukada, Katsuhiko;
    • Kuwano, Hiroyuki
    Publication type:
    Article
    19

    Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.

    Published in:
    Journal of Surgical Oncology, 2018, v. 118, n. 1, p. 101, doi. 10.1002/jso.25127
    By:
    • Gombodorj, Navchaa;
    • Yokobori, Takehiko;
    • Tanaka, Naritaka;
    • Suzuki, Shigemasa;
    • Kuriyama, Kengo;
    • Kumakura, Yuji;
    • Yoshida, Tomonori;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Baatar, Seded;
    • Miyazaki, Tatsuya;
    • Nishiyama, Masahiko;
    • Shirabe, Ken;
    • Kuwano, Hiroyuki
    Publication type:
    Article
    20
    21

    Phase II Study of Docetaxel, Nedaplatin, and 5-Fluorouracil Combined Chemotherapy for Advanced Esophageal Cancer.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 11, p. 3653, doi. 10.1245/s10434-015-4440-4
    By:
    • Miyazaki, Tatsuya;
    • Ojima, Hitoshi;
    • Fukuchi, Minoru;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Tanaka, Naritaka;
    • Suzuki, Shigemasa;
    • Ieta, Keisuke;
    • Saito, Kana;
    • Sano, Akihiko;
    • Yokobori, Takehiko;
    • Inose, Takanori;
    • Nakajima, Masanobu;
    • Kato, Hiroyuki;
    • Kuwano, Hiroyuki
    Publication type:
    Article
    22
    23
    24
    25
    26
    27